ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,014, issued on Sept. 22, was assigned to FRESENIUS KABI DEUTSCHLAND GMBH (Bad Homburg, Germany).
"Liquid pharmaceutical composition comprising an anti-il-6 receptor antibody" was invented by Alessandra Del Rio (Rome) and Carmela Sabina (Tivoli, Italy).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel protein formulation. In particular, the invention relates to a liquid pharmaceutical composition of an antibody directed to Interleukin-6 receptor, a method of manufacturing the composition, a kit including the composition, a package including the composition and to methods of treatment using the composition and/or ...